Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses

Future Microbiology

Volumn 5, Issue 8, 2010, Pages 1233-1255

  Allison, Cody C ^a   Ferrero, Richard L ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Helicobacter pylori; immunity; inflammation; signaling; virulence factor

Indexed keywords

ANTIBODY; CAGA PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; HEAT SHOCK PROTEIN 60; NEUTROPHIL ACTIVATING PROTEIN; OUTER MEMBRANE INFLAMMATORY PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN DUPA; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; UREASE; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CELL INFILTRATION; DNA POLYMORPHISM; DUODENAL ULCER PROMOTING GENE A; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MORBIDITY; NONHUMAN; OPERON; PATHOGENICITY ISLAND; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 77955944141     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.84     Document Type: Review

References (332)

1. Perry S, de la Luz Sanchez M, Yang S et al.: Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg. Infect. Dis. 12(11), 1701-1708 (2006).
2. Brown LM: Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 22(2), 283-297 (2000).
3. Suerbaum S, Michetti P: Helicobacter pylori infection. N. Engl. J. Med. 347(15), 1175-1186 (2002).
4. Graham DY, Go MF, Evans DJ Jr: Review article: urease, gastric ammonium/ ammonia, Helicobacter pylori -the past, the present, recommendations for future research. Aliment Pharmacol. Ther. 6(6), 659-669 (1992).
5. Tsuda M, Karita M, Morshed MG, Okita K, Nakazawa T: A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect. Immun. 62(8), 3586-3589 (1994).
6. Eaton KA, Krakowka S: Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect. Immun. 62(9), 3604-3607 (1994).
7. Eaton KA, Krakowka S: Avirulent, urease-deficient Helicobacter pylori colonizes gastric epithelial explants ex vivo. Scand. J. Gastroenterol. 30(5), 434-437 (1995).
8. Eaton KA, Morgan DR, Krakowka S: Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J. Med. Microbiol. 37(2), 123-127 (1992).
9. Eaton KA, Suerbaum S, Josenhans C, Krakowka S: Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect. Immun. 64(7), 2445-2448 (1996).
10. Odenbreit S, Swoboda K, Barwig I et al.: Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect. Immun. 77(9), 3782-3790 (2009).
11. Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ: Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect. Immun. 68(7), 4155-4168 (2000).
12. Colbeck JC, Hansen LM, Fong JM, Solnick JV: Genotypic profile of the outer membrane proteins BabA, BabB in clinical isolates of Helicobacter pylori. Infect. Immun. 74(7), 4375-4378 (2006).
13. Hennig EE, Allen JM, Cover TL: Multiple chromosomal loci for the babA gene in Helicobacter pylori. Infect. Immun. 74(5), 3046-3051 (2006).
14. Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M: Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc. Natl Acad. Sci. USA 101(7), 2106-2111 (2004).
15. Yamaoka Y, Kwon DH, Graham DY: AM(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl Acad. Sci. USA 97(13), 7533-7538 (2000).
16. Yamaoka Y, Ojo O, Fujimoto S et al.: Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55(6), 775-781 (2006).
17. Odenbreit S, Till M, Haas R: Optimized BlaM-transposon shuttle mutagenesis of Helicobacter pylori allows the identification of novel genetic loci involved in bacterial virulence. Mol. Microbiol. 20(2), 361-373 (1996).
18. Odenbreit S, Till M, Hofreuter D, Faller G, Haas R: Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol. 31(5), 1537-1548 (1999).
19. Odenbreit S, Faller G, Haas R: Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int J. Med. Microbiol. 292(3-4), 247-256 (2002).
20. de Jonge R, Durrani Z, Rijpkema SG, Kuipers EJ, van Vliet AH, Kusters JG: Role of the Helicobacter pylori outer-membrane proteins AlpA, AlpB in colonization of the guinea pig stomach. J. Med. Microbiol. 53(Pt 5), 375-379 (2004).
21. Lu H, Wu JY, Beswick EJ et al.: Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J. Biol. Chem. 282(9), 6242-6254 (2007).
22. Boren T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262(5141), 1892-1895 (1993).
23. Ilver D, Arnqvist A, Ogren J et al.: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279(5349), 373-377 (1998).
24. Mahdavi J, Sonden B, Hurtig M et al.: Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297(5581), 573-578 (2002).
25. Tomb JF, White O, Kerlavage AR et al.: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388(6642), 539-547 (1997).
26. Unemo M, Aspholm-Hurtig M, Ilver D et al.: The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J. Biol. Chem. 280(15), 15390-15397 (2005).
27. Gerhard M, Lehn N, Neumayer N et al.: Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl Acad. Sci. USA 96(22), 12778-12783 (1999).
28. Prinz C, Schoniger M, Rad R et al.: Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 61(5), 1903-1909 (2001).
29. Pride DT, Meinersmann RJ, Blaser MJ: Allelic Variation within Helicobacter pylori babA, babB. Infect. Immun. 69(2), 1160-1171 (2001).
30. Aspholm-Hurtig M, Dailide G, Lahmann M et al.: Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305(5683), 519-522 (2004).
31. Styer CM, Hansen LM, Cooke CL et al.: Expression of the BabA adhesin during experimental infection with Helicobacter pylori. Infect. Immun. 78(4), 1593-1600 (2010).
32. Linden S, Mahdavi J, Semino-Mora C et al.: Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathog. 4(1), e2 (2008).
33. Censini S, Lange C, Xiang Z et al.: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 93(25), 14648-14653 (1996).
34. Alm RA, Ling LS, Moir DT et al.: Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397(6715), 176-180 (1999).
35. Viala J, Chaput C, Boneca IG et al.: Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5(11), 1166-1174 (2004).
36. -driven host cell translocation. Proc. Natl Acad. Sci. USA 97(3), 1263-1268 (2000).
37. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R: Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287(5457), 1497-1500 (2000).
38. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M: Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J. Clin. Microbiol. 39(7), 2463-2465 (2001).
39. Gunn MC, Stephens JC, Stewart JA, Rathbone BJ, West KP: The significance of cagA, vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J. Clin. Pathol. 51(10), 761-764 (1998).
40. Orsini B, Ciancio G, Censini S et al.: Helicobacter pylori cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa. Dig. Liver Dis. 32(6), 458-467 (2000).
41. Wen S, Moss SF: Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett. 282(1), 1-8 (2009).
42. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M: Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J. Biol. Chem. 281(43), 32344-32352 (2006).
43. Asahi M, Azuma T, Ito S et al.: Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 191(4), 593-602 (2000).
44. Peek RM Jr: Orchestration of aberrant epithelial signaling by Helicobacter pylori CagA. Sci STKE2005(277), pe14 (2005).
45. Higashi H, Tsutsumi R, Fujita A et al.: Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl Acad. Sci. USA 99(22), 14428-14433 (2002).
46. Naito M, Yamazaki T, Tsutsumi R et al.: Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130(4), 1181-1190 (2006).
47. Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M: Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell Biol. 26(1), 261-276 (2006).
48. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M: Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA, C-terminal Src kinase. J. Biol. Chem. 278(6), 3664-3670 (2003).
49. Higashi H, Tsutsumi R, Muto S et al.: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295(5555), 683-686 (2002).
50. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC: Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127(2), 514-523 (2004).
51. Azuma T, Ohtani M, Yamazaki Y, Higashi H, Hatakeyama M: Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology 126(7), 1926-1927; author reply 1927-1928 (2004).
52. Azuma T, Yamazaki S, Yamakawa A et al.: Association between diversity in the Src homology 2 domain -containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189(5), 820-827 (2004).
53. Yamaoka Y, El-Zimaity HM, Gutierrez O et al.: Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, susceptibility to low pH. Gastroenterology 117(2), 342-349 (1999).
54. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR: Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 36(8), 2258-2263 (1998).
55. Hatakeyama M: The role of Helicobacter pylori CagA in gastric carcinogenesis. Int. J. Hematol. 84(4), 301-308 (2006).
56. Moese S, Selbach M, Kwok T et al.: Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun. 72(6), 3646-3649 (2004).
57. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS: Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA 96(25), 14559-14564 (1999).
58. Segal ED, Falkow S, Tompkins LS: Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl Acad. Sci. USA 93(3), 1259-1264 (1996).
59. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S: Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300(5624), 1430-1434 (2003).
60. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR: Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl Acad. Sci. USA 102(45), 16339-16344 (2005).
61. Bebb JR, Letley DP, Thomas RJ et al.: Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut 52(10), 1408-1413 (2003).
62. Pillinger MH, Marjanovic N, Kim SY et al.: Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation. J. Biol. Chem. 282(26), 18722-18731 (2007).
63. Wroblewski LE, Noble PJ, Pagliocca A et al.: Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration. J. Cell Sci. 116(Pt 14), 3017-3026 (2003).
64. George SJ, Dwivedi A: MMPs, cadherins, cell proliferation. Trends Cardiovasc. Med. 14(3), 100-105 (2004).
65. Hirata Y, Maeda S, Mitsuno Y et al.: Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology 123(6), 1962-1971 (2002).
66. + Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells. Gut 54(10), 1363-1369 (2005).
67. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M: Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 161(2), 249-255 (2003).
68. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C: Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell. 10(4), 745-755 (2002).
69. + strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl Cancer Inst. 89(12), 863-868 (1997).
70. Rokkas T, Ladas S, Liatsos C et al.: Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig. Dis. Sci. 44(3), 487-493 (1999).
71. Tummuru MK, Cover TL, Blaser MJ: Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun. 62(6), 2609-2613 (1994).
72. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ: Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269(14), 10566-10573 (1994).
73. Kidd M, Lastovica AJ, Atherton JC, Louw JA: Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates. Gut 49(1), 11-17 (2001).
74. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270(30), 17771-17777 (1995).
75. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science 284(5418), 1328-1333 (1999).
76. Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267(15), 10570-10575 (1992).
77. Schmitt W, Haas R: Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 12(2), 307-319 (1994).
78. de Bernard M, Papini E, de Filippis V et al.: Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem. 270(41), 23937-23940 (1995).
79. Yahiro K, Niidome T, Kimura M et al.: Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase p. J. Biol. Chem. 274(51), 36693-36699 (1999).
80. Xiang Z, Censini S, Bayeli PF et al.: Analysis of expression of CagA, VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63(1), 94-98 (1995).
81. Rhead JL, Letley DP, Mohammadi M et al.: A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133(3), 926-936 (2007).
82. Pagliaccia C, de Bernard M, Lupetti P et al.: The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl Acad. Sci. USA 95(17), 10212-10217 (1998).
83. Basso D, Zambon CF, Letley DP et al.: Clinical relevance of Helicobacter pylori cagA, vacA gene polymorphisms. Gastroenterology 135(1), 91-99 (2008).
84. Yahiro K, Wada A, Nakayama M et al.: Protein-tyrosine phosphatase a, RPTP a, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 278(21), 19183-19189 (2003).
85. Padilla PI, Wada A, Yahiro K et al.: Morphologic differentiation of HL-60 cells is associated with appearance of RPTPp and induction of Helicobacter pylori VacA sensitivity. J. Biol. Chem. 275(20), 15200-15206 (2000).
86. Seto K, Hayashi-Kuwabara Y, Yoneta T, Suda H, Tamaki H: Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by the EGF receptor in HeLa cells. FEBS Lett. 431(3), 347-350 (1998).
87. Kuo CH, Wang WC: Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochem. Biophys. Res. Commun. 303(2), 640-644 (2003).
88. Schraw W, Li Y, McClain MS, van der Goot FG, Cover TL: Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J. Biol. Chem. 277(37), 34642-34650 (2002).
89. Gupta VR, Patel HK, Kostolansky SS, Ballivian RA, Eichberg J, Blanke SR: Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog. 4 (5), e1000073 (2008).
90. Fujikawa A, Shirasaka D, Yamamoto S et al.: Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 33(3), 375-381 (2003).
91. Molinari M, Galli C, Norais N et al.: Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J. Biol. Chem. 272(40), 25339-25344 (1997).
92. D'Elios MM, Montecucco C, de Bernard M: VacA, HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation. Clin. Chim. Acta 381(1), 32-38 (2007).
93. Yamasaki E, Wada A, Kumatori A et al.: Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J. Biol. Chem. 281(16), 11250-11259 (2006).
94. de Bernard M, Cappon A, Del Giudice G, Rappuoli R, Montecucco C: The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori. Int. J. Med. Microbiol. 293(7-8), 589-597 (2004).
95. Molinari M, Salio M, Galli C et al.: Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187(1), 135-140 (1998).
96. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R: Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301(5636), 1099-1102 (2003).
97. Boncristiano M, Paccani SR, Barone S et al.: The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198(12), 1887-1897 (2003).
98. Sundrud MS, Torres VJ, Unutmaz D, Cover TL: Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl Acad. Sci. USA 101(20), 7727-7732 (2004).
99. Torres VJ, Van Compernolle SE, Sundrud MS, Unutmaz D, Cover TL: Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T, B lymphocyte subsets. J. Immunol. 179(8), 5433-5440 (2007).
100. + T cells to Helicobacter pylori vacuolating cytotoxin. Infect. Immun. 75(1), 334-341
101. Papini E, Satin B, Norais N et al.: Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102(4), 813-820 (1998).
102. Argent RH, Thomas RJ, Letley DP, Rittig MG, Hardie KR, Atherton JC: Functional association between the Helicobacter pylori virulence factors VacA, CagA. J. Med. Microbiol. 57(Pt 2), 145-150.
103. Asahi M, Tanaka Y, Izumi T et al.: Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter 8(1), 1-14 (2003).
104. Oldani A, Cormont M, Hofman V et al.: Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog. 5(10), e1000603 (2009).
105. Tegtmeyer N, Zabler D, Schmidt D, Hartig R, Brandt S, Backert S: Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA. Cell Microbiol. 11(3), 488-505 (2009).
106. Wessler S, Backert S: Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol. 16(8), 397-405 (2008).
107. Salama NR, Otto G, Tompkins L, Falkow S: Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun. 69(2), 730-736 (2001).
108. Crabtree JE, Ferrero RL, Kusters JG: The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter 7(2), 139-140; author reply 140-1131 (2002).
109. Eaton KA, Cover TL, Tummuru MK, Blaser MJ, Krakowka S: Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 65(8), 3462-3464 (1997).
110. Wirth HP, Beins MH, Yang M, Tham KT, Blaser MJ: Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect. Immun. 66(10), 4856-4866 (1998).
111. Dossumbekova A, Prinz C, Mages J et al.: Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J. Infect. Dis. 194(10), 1346-1355 (2006).
112. Akanuma M, Maeda S, Ogura K et al.: The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease by use of a short-term Mongolian gerbil infection model. J. Infect. Dis. 185(3), 341-347 (2002).
113. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY: Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, mucosal interleukin 8 production. Gastroenterology 123(2), 414-424 (2002).
114. Kudo T, Lu H, Wu JY, Graham DY, Casola A, Yamaoka Y: Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect. Immun. 73(11), 7602-7612 (2005).
115. Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y: Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol. Biol. Cell. 16(10), 4954-4966 (2005).
116. Yamaoka Y, Kita M, Kodama T et al.: Helicobacter pylori infection in mice: role of outer membrane proteins in colonization and inflammation. Gastroenterology 123(6), 1992-2004 (2002).
117. Ando T, Peek RM Jr, Lee YC, Krishna U, Kusugami K, Blaser MJ: Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin. Diagn. Lab. Immunol. 9(1), 167-175 (2002).
118. Brandt S, Kwok T, Hartig R, Konig W, Backert S: NF-kB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl Acad. Sci. USA 102(26), 9300-9305 (2005).
119. de Jonge R, Pot RG, Loffeld RJ, van Vliet AH, Kuipers EJ, Kusters JG: The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome. Helicobacter 9(2), 158-164 (2004).
120. Amedei A, Cappon A, Codolo G et al.: The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 116(4), 1092-1101 (2006).
121. Satin B, Del Giudice G, Della Bianca V et al.: The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191(9), 1467-1476 (2000).
122. Evans DJ Jr, Evans DG, Takemura T et al.: Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63(6), 2213-2220 (1995).
123. Cappon A, Babolin C, Segat D et al.: Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils. Cell Microbiol. 12(6), 754-764 (2010).
124. Namavar F, Sparrius M, Veerman EC, Appelmelk BJ, Vandenbroucke-Grauls CM: Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect. Immun. 66(2), 444-447 (1998).
125. Teneberg S, Miller-Podraza H, Lampert HC et al.: Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J. Biol. Chem. 272(30), 19067-19071 (1997).
126. Long M, Luo J, Li Y, Zeng FY, Li M: Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer. WorldJ. Gastroenterol 15(19), 2381-2388 (2009).
127. Lu H, Hsu PI, Graham DY, Yamaoka Y: Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128(4), 833-848 (2005).
128. Arachchi HS, Kalra V, Lal B et al.: Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population. Helicobacter 12(6), 591-597 (2007).
129. Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H: The Helicobacter pylori duodenal ulcer promoting gene, dupA in China. BMC Gastroenterol. 8, 49 (2008).
130. Douraghi M, Mohammadi M, Oghalaie A et al. : dupA as a risk determinant in Helicobacter pylori infection. J. Med. Microbiol. 57(Pt 5), 554-562 (2008).
131. Argent RH, Burette A, Miendje Deyi VY, Atherton JC: The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin. Infect. Dis. 45(9), 1204-1206 (2007).
132. Gomes LI, Rocha GA, Rocha AM et al.: Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal diseases in Brazilian patients. Int J. Med. Microbiol. 298(3-4), 223-230 (2008).
133. Nguyen LT, Uchida T, Tsukamoto Y et al.: Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population. Clin. Microbiol. Infect. 16(8), 1264-1269 (2010).
134. Schmidt HM, Andres S, Kaakoush NO et al.: The prevalence of the duodenal ulcer promoting gene (dupA) in Helicobacter pylori isolates varies by ethnic group and is not universally associated with disease development: a case-control study. Gut Pathog. 1(1), 5 (2009).
135. Yamaoka Y: Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis. J. Med. Microbiol. 57(Pt 5), 545-553 (2008).
136. Yamaguchi H, Osaki T, Kurihara N et al.: Heat-shock protein 60 homologue of Helicobacter pylori is associated with adhesion of H. pylori to human gastric epithelial cells. J. Med. Microbiol. 46(10), 825-831 (1997).
137. Yamaguchi H, Osaki T, Kurihara N et al.: Induction of secretion of interleuk in-8 from human gastric epithelial cells by heat-shock protein 60 homologue of Helicobacter pylori. J. Med. Microbiol. 48(10), 927-933 (1999).
138. Takenaka R, Yokota K, Ayada K et al.: Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 150(Pt 12), 3913-3922 (2004).
139. Lin SN, Ayada K, Zhao Y et al.: Helicobacter pylori heat-shock protein 60 induces production of the pro-inflammatory cytokine IL8 in monocytic cells. J. Med. Microbiol. 54(Pt 3), 225-233 (2005).
140. Zhao Y, Yokota K, Ayada K et al.: Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes. J. Med. Microbiol. 56(Pt 2), 154-164 (2007).
141. Sharma SA, Miller GG, Peek RA Jr, Perez-Perez G, Blaser MJ: T-cell, antibody, cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection. Clin. Diagn. Lab. Immunol. 4(4), 440-446 (1997).
142. Gobert AP, Bambou JC, Werts C et al.: Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a Toll-like receptor (TLR)-2-, TLR-4-, myeloid differentiation factor 88-independent mechanism. J. Biol. Chem. 279(1), 245-250 (2004).
143. Hayashi S, Sugiyama T, Yokota K et al.: Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation. Clin. Diagn. Lab. Immunol. 5(5), 617-621 (1998).
144. Sharma SA, Miller GG, Perez-Perez GI, Gupta RS, Blaser MJ: Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin. Exp. Immunol. 97(1), 126-132 (1994).
145. Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ: Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 5(2), 70-73 (1997).
146. Kawahara Y, Yokota K, Mizuno M et al.: Antibodies to human gastric epithelial cells and heat shock protein 60 in Helicobacter pylori positive mucosa associated lymphoid tissue lymphoma. Gut 45(1), 20-23 (1999).
147. Tanaka A, Kamada T, Yokota K et al.: Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer. Pathol. Res. Pract. 205(10), 690-694 (2009).
148. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ: Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl Cancer Inst. 87(23), 1777-1780 (1995).
149. Kuehn MJ, Kesty NC: Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19(22), 2645-2655 (2005).
150. Fiocca R, Necchi V, Sommi P et al.: Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J. Pathol. 188(2), 220-226 (1999).
151. Ismail S, Hampton MB, Keenan JI: Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect. Immun. 71(10), 5670-5675 (2003).
152. Keenan J, Day T, Neal S et al.: A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182(2), 259-264 (2000).
153. Aya la G, Torres L , Espinosa M, Fierros-Zarate G, Maldonado V, Melendez-Zajgla J: External membrane vesicles from Helicobacter pylori induce apoptosis in gastric epithelial cells. FEMS Microbiol. Lett. 260(2), 178-185 (2006).
154. Kaparakis M, Turnbull L, Carneiro L et al.: Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol. 12(3), 372-385 (2010).
155. Kirschner DE, Blaser MJ: The dynamics of Helicobacter pylori infection of the human stomach. J. Theor. Biol. 176(2), 281-290 (1995).
156. Robinson K, Argent RH, Atherton JC: The inflammatory and immune response to Helicobacter pylori infection. Best Pract. Res. Clin. Gastroenterol. 21(2), 237-259 (2007).
157. Keates S, Hitti YS, Upton M, Kelly CP: Helicobacter pylori infection activates NF-kB in gastric epithelial cells. Gastroenterology 113(4), 1099-1109 (1997).
158. Sharma SA, Tummuru MK, Miller GG, Blaser MJ: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect. Immun. 63(5), 1681-1687 (1995).
159. Yamaoka Y, Kita M, Kodama T et al.: Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42(5), 609-617 (1998).
160. Mori N, Ueda A, Geleziunas R et al.: Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kB. Infect. Immun. 69(3), 1280-1286 (2001).
161. Mori N, Krensky AM, Geleziunas R et al.: Helicobacter pylori induces RANTES through activation of NF-k B. Infect. Immun. 71(7), 3748-3756 (2003).
162. Chamaillard M, Hashimoto M, Horie Y et al.: An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4(7), 702-707 (2003).
163. Girardin SE, Boneca IG, Carneiro LA et al.: Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300(5625), 1584-1587 (2003).
164. Inohara N, Koseki T, del Peso L et al.: NOD1, an Apaf-1-like activator of caspase-9 and nuclear factor-kB. J. Biol. Chem. 274(21), 14560-14567 (1999).
165. Inohara N, Koseki T, Lin J et al.: An induced proximity model for NF-kB activation in the NOD1/RICK, RIP signaling pathways. J. Biol. Chem. 275(36), 27823-27831 (2000).
166. Kobayashi K, Inohara N, Hernandez LD et al.: RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416(6877), 194-199 (2002).
167. Hasegawa M, Fujimoto Y, Lucas PC et al.: A critical role of RICK/RIP2 polyubiquitination in NOD-induced NF-kB activation. EMBO J. 27(2), 373-383 (2008).
168. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G: NOD2, a NOD1/ Apaf-1 family member that is restricted to monocytes and activates NF-kB. J. Biol. Chem. 276(7), 4812-4818 (2001).
169. Hirata Y, Maeda S, Ohmae T et al.: Helicobacter pylori induces IkB kinase a nuclear translocation and chemokine production in gastric epithelial cells. Infect. Immun. 74(3), 1452-1461 (2006).
170. Maeda S, Yoshida H, Ogura K et al.: H. pylori activates NF-kB through a signaling pathway involving IkB kinases, NF-kB-inducing kinase, TRAF2, TRAF6 in gastric cancer cells. Gastroenterology 119(1), 97-108 (2000).
171. Allison CC, Kufer TA, Kremmer E, Kaparakis M, Ferrero RL: Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J. Immunol. 183(12), 8099-8109 (2009).
172. Grubman A, Kaparakis M, Viala J et al.: The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell Microbiol. 12(5), 626-639 (2009).
173. Rosenstiel P, Hellmig S, Hampe J et al.: Influence of polymorphisms in the NOD1/ CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol. 8(7), 1188-1198 (2006).
174. Peek RM Jr: IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 280(4), G525-G530 (2001).
175. -Helicobacter pylori. J. Immunol. 163(10), 5552-5559 (1999).
176. Naumann M, Wessler S, Bartsch C et al.: Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 274(44), 31655-31662 (1999).
177. +-induced motility of gastric cancer cells. J. Biol. Chem. 283(20), 13952-13963 (2008).
178. Fritz JH, Le Bourhis L, Sellge G et al.: Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26(4), 445-459 (2007).
179. Hirata Y, Ohmae T, Shibata W et al.: MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J. Immunol. 176(6), 3796-3803 (2006).
180. Backhed F, Rokbi B, Torstensson E et al.: Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis. 187(5), 829-836 (2003).
181. Suzuki M, Mimuro H, Kiga K et al.: Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5(1), 23-34 (2009).
182. Lamb A, Yang XD, Tsang YH et al.: Helicobacter pylori CagA activates NF-kB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 10(11), 1242-1249 (2009).
183. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R: Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42(5), 1337-1348 (2001).
184. Foryst-Ludwig A, Neumann M, Schneider-Brachert W, Naumann M: Curcumin blocks NF-kB, the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem. Biophys. Res. Commun. 316(4), 1065-1072 (2004).
185. Neu B, Randlkofer P, Neuhofer M et al.: Helicobacter pylori induces apoptosis of rat gastric parietal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283(2), G309-G318 (2002).
186. Ding SZ, Olekhnovich IN, Cover TL, Peek RM Jr, Smith MF Jr, Goldberg JB: Helicobacter pylori and mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells. FEMS Immunol. Med. Microbiol. 53(3), 385-394 (2008).
187. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL: Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem. 275(21), 16064-16072 (2000).
188. Akira S: Toll-like receptor signaling. J. Biol. Chem. 278(40), 38105-38108 (2003).
189. Aliprantis AO, Yang RB, Mark MR et al.: Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285(5428), 736-739 (1999).
190. Lien E, Sellati TJ, Yoshimura A et al.: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274(47), 33419-33425 (1999).
191. Poltorak A, He X, Smirnova I et al.: Defective LPS signaling in C3H/HeJ, C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396), 2085-2088 (1998).
192. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274(16), 10689-10692 (1999).
193. Nielsen H, Birkholz S, Andersen LP, Moran AP: Neutrophil activation by Helicobacter pylori lipopolysaccharides. J. Infect. Dis. 170(1), 135-139 (1994).
194. Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ: Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect. Immun. 63(4), 1183-1187 (1995).
195. Birkholz S, Knipp U, Nietzki C, Adamek RJ, Opferkuch W: Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol. Med. Microbiol. 6(4), 317-324 (1993).
196. Muotiala A, Helander IM, Pyhala L, Kosunen TU, Moran AP: Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 60(4), 1714-1716 (1992).
197. Moran AP: Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr. Res. 343(12), 1952-1965 (2008).
198. Moran AP, Helander IM, Kosunen TU: Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 174(4), 1370-1377 (1992).
199. Moran AP, Lindner B, Walsh EJ: Structural characterization of the lipid A component of Helicobacter pylori rough-and smooth-form lipopolysaccharides. J. Bacteriol. 179(20), 6453-6463 (1997).
200. Aspinall GO, Monteiro MA: Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry 35(7), 2498-2504 (1996).
201. Aspinall GO, Monteiro MA, Pang H, Walsh EJ, Moran AP: Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 35(7), 2489-2497 (1996).
202. Lepper PM, Triantafilou M, Schumann C, Schneider EM, Triantafilou K: Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol. 7(4), 519-528 (2005).
203. Smith MF Jr, Mitchell A, Li G et al.: Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-k B activation and chemokine expression by epithelial cells. J. Biol. Chem. 278(35), 32552-32560 (2003).
204. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K: Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol. Med. Microbiol. 51(1), 140-148 (2007).
205. Yokota S, Okabayashi T, Rehli M, Fujii N, Amano K: Helicobacter pylori lipopolysaccharides upregulate Toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect. Immun. 78(1), 468-476 (2010).
206. Chochi K, Ichikura T, Kinoshita M et al.: Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-Toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin. Cancer Res. 14(10), 2909-2917 (2008).
207. Ishihara S, Rumi MA, Kadowaki Y et al.: Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J. Immunol. 173(2), 1406-1416 (2004).
208. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K: Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69(7), 4382-4389 (2001).
209. Uno K, Kato K, Atsumi T et al.: Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293(5), G1004-G1012 (2007).
210. Mandell L, Moran AP, Cocchiarella A et al.: Intact Gram-negative Helicobacter pylori, Helicobacter felis, Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect. Immun. 72(11), 6446-6454 (2004).
211. Maeda S, Akanuma M, Mitsuno Y et al.: Distinct mechanism of Helicobacter pylori-mediated NF-k B activation between gastric cancer cells and monocytic cells. J. Biol. Chem. 276(48), 44856-44864 (2001).
212. Fujita M, Into T, Yasuda M et al.: Involvement of leucine residues at positions 107, 112, 115 in a leucine-rich repeat motif of human Toll-like receptor 2 in the recognition of diacylated lipoproteins and lipopeptides and Staphylococcus aureus peptidoglycans. J. Immunol. 171(7), 3675-3683 (2003).
213. Del Prete G, Chiumiento L, Amedei A et al.: Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein. J. Allergy Clin. Immunol. 122(5), 908.e5-913.e5 (2008).
214. Schmausser B, Andrulis M, Endrich S et al.: Expression and subcellular distribution of Toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin. Exp. Immunol. 136(3), 521-526 (2004).
215. Rad R, Ballhorn W, Voland P et al.: Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 136(7), 2247-2257 (2009).
216. Obonyo M, Sabet M, Cole SP et al.: Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect. Immun. 75(5), 2408-2414 (2007).
217. Rad R, Brenner L, Krug A et al.: Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 133(1), 150.e3-163.e3 (2007).
218. Hayashi F, Smith KD, Ozinsky A et al.: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410(6832), 1099-1103 (2001).
219. Lee SK, Stack A, Katzowitsch E, Aizawa SI, Suerbaum S, Josenhans C: Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 5(15), 1345-1356 (2003).
220. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr: Helicobacter pylori flagellin evades Toll-like receptor 5-mediated innate immunity. J. Infect. Dis. 189(10), 1914-1920 (2004).
221. Andersen-Nissen E, Smith KD, Strobe KL et al.: Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl Acad. Sci. USA 102(26), 9247-9252 (2005).
222. Chaouche-Drider N, Kaparakis M, Karrar A et al.: A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cells. PLoS One 4(4), e5396 (2009).
223. Kwok T, Zabler D, Urman S et al.: Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449(7164), 862-866 (2007).
224. Jimenez-Soto LF, Kutter S, Sewald X et al.: Helicobacter pylori type IV secretion apparatus exploits p1 integrin in a novel RGD-independent manner. PLoS Pathog. 5(12), e1000684 (2009).
225. Tegtmeyer N, Hartig R, Delahay RM et al.: A small fibronectin-mimicking protein from bacteria induces cell spreading and focal adhesion formation. J. Biol. Chem. 285(30), 23515-23526 (2010).
226. Saha A, Backert S, Hammond CE, Gooz M, Smolka AJ: Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase a subunit. Gastroenterology 139(1), 239-248 (2010).
227. Crabtree JE, Farmery SM, Lindley IJ, Figura N, Peichl P, Tompkins DS: CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J. Clin. Pathol. 47(10), 945-950 (1994).
228. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Mucosal tumour necrosis factor a and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32(12), 1473-1477 (1991).
229. Crabtree JE, Wyatt JI, Trejdosiewicz LK et al.: Interleukin-8 expression in Helicobacter pylori infected, normal, neoplastic gastroduodenal mucosa. J. Clin. Pathol. 47(1), 61-66 (1994).
230. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J: Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110(6), 1744-1752 (1996).
231. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41(4), 442-451
232. Shimoyama T, Everett SM, Dixon MF, Axon AT, Crabtree JE: Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J. Clin. Pathol. 51(10), 765-770
233. Isomoto H, Mukae H, Ishimoto H et al.: Elevated concentrations of a-defensins in gastric juice of patients with Helicobacter pylori infection. Am. J. Gastroenterol. 99(10), 1916-1923 (2004).
234. Isomoto H, Mukae H, Ishimoto H et al.: High concentrations of human p-defensin 2 in gastric juice of patients with Helicobacter pylori infection. World J. Gastroenterol. 11(31), 4782-4787 (2005).
235. Hase K, Murakami M, Iimura M et al.: Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125(6), 1613-1625 (2003).
236. George JT, Boughan PK, Karageorgiou H, Bajaj-Elliott M: Host anti-microbial response to Helicobacter pylori infection. Mol. Immunol. 40(7), 451-456 (2003).
237. Hamanaka Y, Nakashima M, Wada A et al.: Expression of human p-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 49(4), 481-487 (2001).
238. Uehara N, Yagihashi A, Kondoh K et al.: Human p-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression. J. Med. Microbiol. 52(Pt 1), 41-45 (2003).
239. Boughan PK, Argent RH, Body-Malapel M et al.: Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of p-defensins during Helicobacter pylori infection. J. Biol. Chem. 281(17), 11637-11648 (2006).
240. Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV: Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology 134(4), 1049-1057 (2008).
241. Otte JM, Neumann HM, Brand S, Schrader H, Schmidt WE, Schmitz F: Expression of p-defensin 4 is increased in human gastritis. Eur J. Clin. Invest. 39(2), 126-138 (2009).
242. Kocsis AK, Kiss ZF, Tiszlavicz L, Tiszlavicz Z, Mandi Y: Potential role of human p-defensin 1 in Helicobacter pylori-induced gastritis. Scand. J. Gastroenterol. 44(3), 289-295 (2009).
243. Bajaj-Elliott M, Fedeli P, Smith GV et al.: Modulation of host antimicrobial peptide (p-defensins 1 and 2) expression during gastritis. Gut 51(3), 356-361 (2002).
244. Rohrl J, Yang D, Oppenheim JJ, Hehlgans T: Specific binding and chemotactic activit y of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J. Biol. Chem. 285(10), 7028-7034 (2010).
245. Yang D, Chertov O, Bykovskaia SN et al.: p-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286(5439), 525-528 (1999).
246. Soruri A, Grigat J, Forssmann U, Riggert J, Zwirner J: p-defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J. Immunol. 37(9), 2474-2486 (2007).
247. Nielsen H, Andersen LP: Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 103(6), 1747-1753 (1992).
248. Craig PM, Territo MC, Karnes WE, Walsh JH: Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 33(8), 1020-1023 (1992).
249. Mai UE, Perez-Perez GI, Allen JB, Wahl SM, Blaser MJ, Smith PD: Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J. Exp. Med. 175(2), 517-525 (1992).
250. Nielsen H, Andersen LP: Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes. Gut 33(6), 738-742 (1992).
251. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD: Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Invest. 87(3), 894-900 (1991).
252. Noorgaard A, Andersen LP, Nielsen H: Neutrophil degranulation by Helicobacter pylori proteins. Gut 36(3), 354-357 (1995).
253. Eaton KA, Ringler SR, Danon SJ: Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infect. Immun. 67(9), 4594-4602 (1999).
254. Eaton KA, Mefford M, Thevenot T: The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 166(12), 7456-7461 (2001).
255. Allen LA: Phagocytosis and persistence of Helicobacter pylori. Cell Microbiol. 9(4), 817-828 (2007).
256. Darwin PE, Sztein MB, Zheng QX, James SP, Fantry GT: Immune evasion by Helicobacter pylori: gastric spiral bacteria lack surface immunoglobulin deposition and reactivity with homologous antibodies. Helicobacter 1(1), 20-27 (1996).
257. Rautelin H, Blomberg B, Jarnerot G, Danielsson D: Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand. J. Gastroenterol. 29(2), 128-132 (1994).
258. Rokita E, Makristathis A, Presterl E, Rotter ML, Hirschl AM: Helicobacter pylori urease significantly reduces opsonization by human complement. J. Infect. Dis. 178(5), 1521-1525 (1998).
259. Allen LA, Schlesinger LS, Kang B: Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 191(1), 115-128 (2000).
260. Ramarao N, Gray-Owen SD, Backert S, Meyer TF: Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol. Microbiol. 37(6), 1389-1404 (2000).
261. Ramarao N, Meyer TF: Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and fluorescence-activated cell sorting. Infect. Immun. 69(4), 2604-2611 (2001).
262. Wilson KT, Ramanujam KS, Mobley HL, Musselman RF, James SP, Meltzer SJ: Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 111(6), 1524-1533 (1996).
263. Gobert AP, McGee DJ, Akhtar M et al.: Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl Acad. Sci. USA 98(24), 13844-13849 (2001).
264. Allen LA, Beecher BR, Lynch JT, Rohner OV, Wittine LM: Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J. Immunol. 174(6), 3658-3667 (2005).
265. Bryk R, Griffin P, Nathan C: Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407(6801), 211-215 (2000).
266. Droge W: Free radicals in the physiological control of cell function. Physiol. Rev. 82(1), 47-95 (2002).
267. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20(10), 2175-2183 (2000).
268. Jhala NC, Siegal GP, Klemm K, Atkinson BF, Jhala DN: Infiltration of Helicobacter pylori in the gastric mucosa. Am. J. Clin. Pathol. 119(1), 101-107 (2003).
269. Shanks AM, El-Omar EM: Helicobacter pylori infection, host genetics and gastric cancer. J. Dig. Dis. 10(3), 157-164 (2009).
270. El-Omar EM, Oien K, Murray LS et al.: Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 118(1), 22-30 (2000).
271. El-Omar EM, Rabkin CS, Gammon MD et al.: Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124(5), 1193-1201 (2003).
272. Figueiredo C, Machado JC, Pharoah P et al.: Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl Cancer Inst. 94(22), 1680-1687 (2002).
273. Beales IL, Calam J: Interleukin 1 p and tumour necrosis factor a inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42(2), 227-234 (1998).
274. Tu S, Bhagat G, Cui G et al.: Overexpression of interleukin-1p induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 14(5), 408-419 (2008).
275. Machado JC, Figueiredo C, Canedo P et al.: A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125(2), 364-371 (2003).
276. Hold GL, Rabkin CS, Chow WH et al.: A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132(3), 905-912 (2007).
277. Taguchi A, Ohmiya N, Shirai K et al.: Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 14(11 Pt 1), 2487-2493 (2005).
278. Hofner P, Gyulai Z, Kiss ZF et al.: Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 12(2), 124-131 (2007).
279. Kara B, Akkiz H, Doran F et al.: The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis? Clin. Exp. Med. 10(2), 107-112 (2009).
280. Wilson KT, Crabtree JE: Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133(1), 288-308 (2007).
281. Caruso R, Pallone F, Monteleone G: Emerging role of IL-23/IL-17 axis in H. pylon-associated pathology. World J. Gastroenterol. 13(42), 5547-5551 (2007).
282. Farrar JD, Asnagli H, Murphy KM: T helper subset development: roles of instruction, selection, transcription. J. Clin. Invest. 109(4), 431-435 (2002).
283. + T-cell clones from peripheral blood and gastric biopsies. Infect. Immun. 63(3), 1102-1106 (1995).
284. Fan XJ, Chua A, Shahi CN, McDevitt J, Keeling PW, Kelleher D: Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation. Gut 35(10), 1379-1384 (1994).
285. Bamford KB, Fan X, Crowe SE et al.: Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114(3), 482-492 (1998).
286. D'Elios MM, Manghetti M, De Carli M et al. : T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158(2), 962-967 (1997).
287. Karttunen R, Karttunen T, Ekre HP, MacDonald TT: Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 36(3), 341-345
288. Sawai N, Kita M, Kodama T et al.: Role of g interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun. 67(1), 279-285 (1999).
289. Lehmann FS, Terracciano L, Carena I et al.: In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am. J. Physiol. Gastrointest. Liver Physiol. 283(2), G481-G488 (2002).
290. Cui G, Houghton J, Finkel N, Carlson J, Wang TC: IFN-g infusion induces gastric atrophy, metaplasia and dysplasia in the absence of Helicobacter infection-a role for immune response in Helicobacter disease. Gastroenterology 124(4 Suppl. 1), A19 (2003).
291. Zavros Y, Rathinavelu S, Kao JY et al.: Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc. Natl Acad. Sci. USA 100(22), 12944-12949 (2003).
292. Mohammadi M, Czinn S, Redline R, Nedrud J: Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156(12), 4729-4738
293. Garhart CA, Heinzel FP, Czinn SJ, Nedrud JG: Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect. Immun. 71(2), 910-921 (2003).
294. Akhiani AA, Pappo J, Kabok Z et al.: Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169(12), 6977-6984 (2002).
295. + T cell-mediated IFN-g response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J. Immunol. 182(11), 7085-7101 (2009).
296. + T cells. Arthritis Res. Ther. 11(6), 257 (2009).
297. Miossec P: IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect. 11(5), 625-630 (2009).
298. Aujla SJ, Dubin PJ, Kolls JK: Th17 cells and mucosal host defense. Semin. Immunol. 19(6), 377-382 (2007).
299. Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity 21(4), 467-476 (2004).
300. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL: Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol. Med. Microbiol. 51(3), 577-586 (2007).
301. Luzza F, Parrello T, Monteleone G et al.: Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165(9), 5332-5337 (2000).
302. DeLyria ES, Redline RW, Blanchard TG: Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136(1), 247-256 (2009).
303. Velin D, Favre L, Bernasconi E et al.: Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136(7), 2237.e1-2246.e1 (2009).
304. + T lymphocytes. Infect. Immun. 78(2), 845-853 (2010).
305. Kao JY, Zhang M, Miller MJ et al.: Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138(3), 1046-1054 (2010).
306. Mitchell P, Germain C, Fiori PL et al.: Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun. 75(2), 810-819 (2007).
307. + CD25hlgh regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71(4), 1755-1762 (2003).
308. Raghavan S, Suri-Payer E, Holmgren J: Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells. Scand. J. Immunol. 60(1-2), 82-88 (2004).
309. + CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73(1), 523-531 (2005).
310. + T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131(2), 525-537 (2006).
311. Robinson K, Kenefeck R, Pidgeon EL et al.: Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut. 57(10), 1375-1385 (2008).
312. Harris PR, Wright SW, Serrano C et al.: Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134(2), 491-499 (2008).
313. Hida N, Shimoyama T Jr, Neville P et al.: Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J. Clin. Pathol. 52(9), 658-664 (1999).
314. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM: Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 66(12), 5964-5971 (1998).
315. + Tregs: limiting collateral damage. J. Clin. Invest. 114(10), 1372-1378 (2004).
316. Thompson C, Powrie F: Regulatory T cells. Curr. Opin. Pharmacol. 4(4), 408-414 (2004).
317. Weiner HL: Induction and mechanism of action of transforming growth factor-p-secreting Th3 regulatory cells. Immunol Rev. 182, 207-214 (2001).
318. Atherton JC: The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol. 1, 63-96 (2006).
319. Nurgalieva ZZ, Conner ME, Opekun AR et al.: B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect. Immun. 73(5), 2999-3006 (2005).
320. Mattsson A, Quiding-Jarbrink M, Lonroth H, Hamlet A, Ahlstedt I, Svennerholm A: Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect. Immun. 66(6), 2705-2712 (1998).
321. Bogstedt AK, Nava S, Wadstrom T, Hammarstrom L: Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin. Exp. Immunol. 105(2), 202-204 (1996).
322. Akhiani AA, Stensson A, Schon K, Lycke NY: IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J. Immunol. 174(12), 8144-8153 (2005).
323. Carlsson F, Berggard K, Stalhammar-Carlemalm M, Lindahl G: Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J. Exp. Med. 198(7), 1057-1068 (2003).
324. Russell MW, Reinholdt J, Kilian M: Anti-inflammatory activity of human IgA antibodies and their Fab a fragments: inhibition of IgG-mediated complement activation. Eur J. Immunol. 19(12), 2243-2249 (1989).
325. Akhiani AA, Schon K, Franzen LE, Pappo J, Lycke N: Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, counteract resistance against infection. J. Immunol. 172(8), 5024-5033 (2004).
326. Ermak TH, Giannasca PJ, Nichols R et al.: Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188(12), 2277-2288 (1998).
327. Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ: Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect. Immun. 71(6), 3628-3633 (2003).
328. Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A: Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol. Cell Biol. 78(1), 28-30 (2000).
329. Blanchard TG, Eisenberg JC, Matsumoto Y: Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy. Vaccine 22(7), 888-897 (2004).
330. Ferrero RL, Thiberge JM, Labigne A: Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology 113(1), 185-194 (1997).
331. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG: Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell Immunol. 191(1), 74-80 (1999).
332. Gorrell RJ, Robins-Browne RM: Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect. Immun. 77(11), 5116-5129 (2009)